Authors:
Klein, MA
Kaeser, PS
Schwarz, P
Weyd, H
Xenarios, I
Zinkernagel, RM
Carroll, MC
Verbeek, JS
Botto, M
Walport, MJ
Molina, H
Kalinke, U
Acha-Orbea, H
Aguzzi, A
Citation: Ma. Klein et al., Complement facilitates early prion pathogenesis, NAT MED, 7(4), 2001, pp. 488-492
Authors:
Heppner, FL
Musahl, C
Arrighi, I
Klein, MA
Rulicke, T
Oesch, B
Zinkernagel, RM
Kalinke, U
Aguzzi, A
Citation: Fl. Heppner et al., Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies, SCIENCE, 294(5540), 2001, pp. 178-182
Authors:
Seiler, P
Senn, BM
Klenerman, P
Kalinke, U
Hengartner, H
Zinkernagel, RM
Citation: P. Seiler et al., Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence, J VIROLOGY, 74(13), 2000, pp. 5896-5901
Authors:
Karrer, U
Lopez-Macias, C
Oxenius, A
Odermatt, B
Bachmann, MF
Kalinke, U
Bluethmann, H
Hengartner, H
Zinkernagel, RM
Citation: U. Karrer et al., Antiviral B cell memory in the absence of mature follicular dendritic cellnetworks and classical germinal centers in TNFR1(-/-) mice, J IMMUNOL, 164(2), 2000, pp. 768-778
Authors:
Seiler, P
Senn, BM
Brundler, MA
Zinkernagel, RM
Hengartner, H
Kalinke, U
Citation: P. Seiler et al., In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody, J IMMUNOL, 162(8), 1999, pp. 4536-4541
Authors:
Lopez-Macias, C
Kalinke, U
Cascalho, M
Wabl, M
Hengartner, H
Zinkernagel, RM
Lamarre, A
Citation: C. Lopez-macias et al., Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses, J EXP MED, 189(11), 1999, pp. 1791-1798